Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Urgent Surgery Is Not Always Necessary To Treat Stroke Caused By Brain Haemorrhage

28.01.2005


The results of a major international Medical Research Council (MRC) trial, undertaken in collaboration with the Stroke Association, show that early surgery is not always the best treatment for one of the commonest and most lethal forms of stroke. The results of the trial, published in this week’s edition of The Lancet, will help doctors decide the best way to care for patients with the condition.



Supratentorial intracerebral haemorrhage (ICH) is a type of stroke caused by the spontaneous rupture of a blood vessel in the brain and there has been much uncertainty about the best way to treat it. Anecdotal evidence suggests that early surgery to remove the resulting blood clot limits damage to the surrounding tissue and improves recovery by allowing the blood to circulate more freely. However, brain imaging studies to date have failed to provide conclusive evidence for or against this and previous clinical trials have given mixed results.

The MRC STICH* trial was specifically designed to answer this question. The scientists studied over 1,000 patients recruited from 27 countries to find out if early surgery is better than careful observation.


The results showed no statistical differences in the number of people who died or the degree of disability in survivors between the two policies. However, those patients with blood clots near the surface of the brain were found to be more likely to benefit while patients in a coma seemed less likely to benefit from early surgery.

Patients were only eligible to take part in the trial if, on admission to casualty, a brain scan showed they had had an ICH in the last 72 hours and if their brain surgeon was uncertain whether or not to perform surgery. In addition to the usual medical care the patients were randomly assigned to early surgery or careful observation with delayed surgery only if necessary.

Dr David Mendelow, from Newcastle led the trial. He said: “The results will help us decide better how to manage patients with this type of stroke – careful clinical observation and surgery can be life-saving but there’s no need to rush in with an operation, except perhaps in those patients where the blood clot is significantly close to the surface. This type of clot should not be confused with the type of clot that occurs after an injury.”

Dr Joanne Knight, Associate Director of Research and Development for The Stroke Association, said: “The Stroke Association welcomes this new research which is the biggest ever neurosurgical collaboration and will have a significant influence on practice internationally. “We’re pleased to learn this research will now give consultants the evidence they need to decide on the best treatment for stroke patients. It will also mean that patients will not have to go through the stress of surgery unless it’s beneficial to their condition.”

ICH accounts for a fifth of all stroke-related conditions. More than 40 per cent of patients with ICH die and the majority of survivors are disabled.

Press Office | alfa
Further information:
http://www.mrc.ac.uk

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>